Why the study?
Does mapping and radiofrequency ablation safely treat severe drug-resistant tachyarrhythmia in pregnant women?
Population
9 pregnant women at 12-38th week of pregnancy with severe drug-resistant tachyarrhythmia.
Design
Case_series
Follow-up
mean 43 +/- 23 months
Authors
Loading...
Supports ablation feasibility in drug-refractory pregnant cases; hypothesis-generating and requires prospective confirmation before practice change.
Does mapping and radiofrequency ablation safely treat severe drug-resistant tachyarrhythmia in pregnant women?
Radiofrequency ablation with minimal or no X-ray exposure can be performed safely and effectively in pregnant women with severe, drug-resistant tachyarrhythmias.
Szumowski et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: